Ashish Jha writes that AI is eroding the barriers that kept biological weapons rare

STAT · Public essay

Read the source (opens in a new tab)
What happened
In a STAT First Opinion essay, Ashish Jha, a former White House Covid-19 response coordinator and senior fellow at Harvard Kennedy School's Belfer Center, argued biological threats are outpacing defenses.
Key points
  • He writes that biological weapons were rare because the needed expertise was hard to combine, and "AI is closing those gaps" by connecting ideas across subfields.
  • He cites two reports this year, from Harvard and RAND, concluding AI "could broaden the range of actors able to mount a large-scale biological attack," while also aiding state programs.
  • He says broad restrictions would also slow new therapies, and calls instead for layered defense: overseen researcher access, pre-release testing for dangerous capabilities, and audited customer checks by DNA synthesis providers.
  • He says slowing model development is "worth doing," but only as "a bridge to building biodefense," concluding "Defenses against this threat take years to build. We don't have years to spare."
Evidence
An argument by a public health official in a publication's opinion section, not new data. It draws on published reports, Anthropic's disclosed misuse cases and a Nature Communications experiment.
Uncertain
Jha writes that neither the Harvard nor the RAND report claims the most dangerous thresholds have been crossed, "though neither rules it out." He is co-founder and CEO of BioRadar, a biological threat detection company.

See it in the latest record